Literature DB >> 33377643

The roles of exosomes in cancer drug resistance and its therapeutic application.

Shiyu Li1, Ming Yi1, Bing Dong2, Ying Jiao1, Suxia Luo3, Kongming Wu1,3.   

Abstract

Exosomes are a category of extracellular vesicles with a size ranging from 40 to 160 nm, which can be secreted by multiple cells in the tumor microenvironment. Exosomes serve as communicators in regulating biological functions and pathological processes, including drug response. Through transporting the cargo such as protein or nucleic acid, exosomes can modulate drug sensitivity via multiple mechanisms. Additionally, exosomes can be deployed as a delivery system to treat cancer due to their high-efficient loading capacity and tolerable toxicity. Recent studies have demonstrated the high efficacy of exosomes in cancer therapy. Herein, we conduct this review to summarize the mechanism of exosome-mediated drug resistance and the therapeutic potential of exosomes in cancer.
© 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

Entities:  

Keywords:  cancer; drug resistance; exosomes; therapeutic application

Year:  2020        PMID: 33377643      PMCID: PMC7752167          DOI: 10.1002/ctm2.257

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN: 2001-1326


  137 in total

Review 1.  Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance.

Authors:  M Helena Vasconcelos; Hugo R Caires; Artūrs Ābols; Cristina P R Xavier; Aija Linē
Journal:  Drug Resist Updat       Date:  2019-10-15       Impact factor: 18.500

2.  Structural features of the interaction of the 3'-untranslated region of mRNA containing exosomal RNA-specific motifs with YB-1, a potential mediator of mRNA sorting.

Authors:  Darya D Yanshina; Olga A Kossinova; Alexander V Gopanenko; Olga A Krasheninina; Alexey A Malygin; Alya G Venyaminova; Galina G Karpova
Journal:  Biochimie       Date:  2017-11-11       Impact factor: 4.079

3.  Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.

Authors:  Uchini S Kosgodage; Rita P Trindade; Paul R Thompson; Jameel M Inal; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

Review 4.  Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm.

Authors:  Kan Yin; Shihua Wang; Robert Chunhua Zhao
Journal:  Biomark Res       Date:  2019-04-04

5.  Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.

Authors:  Stefania Raimondo; Laura Saieva; Emanuela Vicario; Marzia Pucci; Denise Toscani; Mauro Manno; Samuele Raccosta; Nicola Giuliani; Riccardo Alessandro
Journal:  J Hematol Oncol       Date:  2019-01-08       Impact factor: 17.388

6.  Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.

Authors:  Gaofeng Liang; Yanliang Zhu; Doulathunnisa Jaffar Ali; Tian Tian; Huantian Xu; Ke Si; Bo Sun; Baoan Chen; Zhongdang Xiao
Journal:  J Nanobiotechnology       Date:  2020-01-09       Impact factor: 10.435

7.  Exosome-mediated breast cancer chemoresistance via miR-155 transfer.

Authors:  Juliana Carvalho Santos; Natália da Silva Lima; Luis Otavio Sarian; Ander Matheu; Marcelo Lima Ribeiro; Sophie Françoise Mauricette Derchain
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

8.  Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.

Authors:  Xinyi Wang; Haiyang Zhang; Haiou Yang; Ming Bai; Tao Ning; Ting Deng; Rui Liu; Qian Fan; Kegan Zhu; Jialu Li; Yang Zhan; Guoguang Ying; Yi Ba
Journal:  Mol Oncol       Date:  2020-01-24       Impact factor: 6.603

9.  Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.

Authors:  Mingli Han; Jianguo Hu; Pengwei Lu; Hui Cao; Chao Yu; Xiangke Li; Xueke Qian; Xue Yang; Yunqing Yang; Na Han; Dongwei Dou; Fan Zhang; Mulin Ye; Changcheng Yang; Yuanting Gu; Huaying Dong
Journal:  Cell Death Dis       Date:  2020-01-22       Impact factor: 8.469

10.  lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.

Authors:  Xiliu Chen; Zhongliang Wang; Fan Tong; Xiaorong Dong; Gang Wu; Ruiguang Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-29       Impact factor: 8.886

View more
  20 in total

Review 1.  Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.

Authors:  Zainuddin Quadri; Ahmed Elsherbini; Erhard Bieberich
Journal:  Pharmacol Res       Date:  2021-12-02       Impact factor: 7.658

Review 2.  Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets.

Authors:  Jiongjia Cheng; Xiaofeng Wang; Xuechun Yuan; Guangxiang Liu; Qian Chu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 3.  Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Authors:  Mengke Niu; Ming Yi; Ning Li; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-03-02

Review 4.  The role of exosomes in lung cancer metastasis and clinical applications: an updated review.

Authors:  Lei Yin; Xiaotian Liu; Xuejun Shao; Tao Feng; Jun Xu; Qi Wang; Shenghao Hua
Journal:  J Transl Med       Date:  2021-07-19       Impact factor: 5.531

Review 5.  MiRNA-mediated EMT and CSCs in cancer chemoresistance.

Authors:  Bing Dong; Shiyu Li; Shuangli Zhu; Ming Yi; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-02-12

6.  Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4.

Authors:  Tianxin Lyu; Yinuo Wang; Ding Li; Hui Yang; Bin Qin; Wenli Zhang; Zhiyue Li; Cheng Cheng; Binglei Zhang; Rongqun Guo; Yongping Song
Journal:  Exp Hematol Oncol       Date:  2021-03-31

7.  Roles of pulmonary telocytes in airway epithelia to benefit experimental acute lung injury through production of telocyte-driven mediators and exosomes.

Authors:  Li Tang; Dongli Song; Ruixue Qi; Bijun Zhu; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2022-01-03       Impact factor: 6.691

8.  Different Ability of Multidrug-Resistant and -Sensitive Counterpart Cells to Release and Capture Extracellular Vesicles.

Authors:  Diana Sousa; Raquel T Lima; Vanessa Lopes-Rodrigues; Esperanza Gonzalez; Félix Royo; Cristina P R Xavier; Juan M Falcón-Pérez; M Helena Vasconcelos
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 9.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.

Authors:  Lijun Chen; Jingjing Qu; Quanhui Mei; Xin Chen; Yangxin Fang; Lu Chen; Yifei Li; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

Review 10.  Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.

Authors:  Yiyi Yao; Fenglin Li; Jiansong Huang; Jie Jin; Huafeng Wang
Journal:  Exp Hematol Oncol       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.